Literature DB >> 7830934

Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression.

W S Griffin1, J G Sheng, S M Gentleman, D I Graham, R E Mrak, G W Roberts.   

Abstract

Activated microglia containing IL-1 alpha-immunoreactive (IL-1 alpha +) product were increased 3-fold in number in the acute phase following head injury, a risk factor for later development of Alzheimer's disease, and this increase was correlated with a 7-fold increase in the number of neurons with elevated beta-amyloid precursor protein (beta-APP) levels (R = 0.78; P < 0.05). Furthermore, clusters of beta-APP+ dystrophic neurites present in these patients were invariably associated with activated IL-1 alpha + microglia. These findings suggest that early overexpression of IL-1 alpha and beta-APP is a priming event for later neuropathological changes evident at end stages of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7830934      PMCID: PMC3833643          DOI: 10.1016/0304-3940(94)90066-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  25 in total

1.  Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.

Authors:  D R Marshak; S A Pesce; L C Stanley; W S Griffin
Journal:  Neurobiol Aging       Date:  1992 Jan-Feb       Impact factor: 4.673

Review 2.  Alzheimer's disease: environmental factors and etiologic hypotheses.

Authors:  D Gautrin; S Gauthier
Journal:  Can J Neurol Sci       Date:  1989-11       Impact factor: 2.104

3.  Cytokine regulation of neuronal survival.

Authors:  D E Brenneman; M Schultzberg; T Bartfai; I Gozes
Journal:  J Neurochem       Date:  1992-02       Impact factor: 5.372

4.  Dementia in a punch-drunk wife.

Authors:  G W Roberts; H L Whitwell; P R Acland; C J Bruton
Journal:  Lancet       Date:  1990-04-14       Impact factor: 79.321

Review 5.  Molecular pathology of head trauma: altered beta APP metabolism and the aetiology of Alzheimer's disease.

Authors:  S M Gentleman; D I Graham; G W Roberts
Journal:  Prog Brain Res       Date:  1993       Impact factor: 2.453

6.  Alzheimer's disease: prospects for treatment.

Authors:  G W Roberts; S M Gentleman; M D Stefan; M C Royston
Journal:  Lancet       Date:  1993-02-13       Impact factor: 79.321

7.  Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.

Authors:  J D Buxbaum; M Oishi; H I Chen; R Pinkas-Kramarski; E A Jaffe; S E Gandy; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Beta-amyloid precursor protein isoforms in various rat brain regions and during brain development.

Authors:  J Löffler; G Huber
Journal:  J Neurochem       Date:  1992-10       Impact factor: 5.372

9.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury.

Authors:  S M Gentleman; M J Nash; C J Sweeting; D I Graham; G W Roberts
Journal:  Neurosci Lett       Date:  1993-10-01       Impact factor: 3.046

View more
  45 in total

1.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

Review 2.  Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.

Authors:  Kenneth H Clark; Clayton A Wiley; Charles W Bradberry
Journal:  Neurotox Res       Date:  2012-06-20       Impact factor: 3.911

3.  Frontal cortex neuropathology in dementia pugilistica.

Authors:  Tommy Saing; Malcolm Dick; Peter T Nelson; Ronald C Kim; David H Cribbs; Elizabeth Head
Journal:  J Neurotrauma       Date:  2012-04-10       Impact factor: 5.269

Review 4.  The multifaceted profile of activated microglia.

Authors:  Marina A Lynch
Journal:  Mol Neurobiol       Date:  2009-07-23       Impact factor: 5.590

5.  Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

Authors:  R E Mrak; J G Sheng; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

6.  The neuroinflammatory response in humans after traumatic brain injury.

Authors:  C Smith; S M Gentleman; P D Leclercq; L S Murray; W S T Griffin; D I Graham; J A R Nicoll
Journal:  Neuropathol Appl Neurobiol       Date:  2013-10       Impact factor: 8.090

7.  Inflammatory consequences in a rodent model of mild traumatic brain injury.

Authors:  J Regino Perez-Polo; Harriet C Rea; Kathia M Johnson; Margaret A Parsley; Geda C Unabia; Guojing Xu; Smitha K Infante; Douglas S Dewitt; Claire E Hulsebosch
Journal:  J Neurotrauma       Date:  2013-05-06       Impact factor: 5.269

8.  Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice.

Authors:  J G Sheng; R E Mrak; K R Bales; B Cordell; S M Paul; R A Jones; S Woodward; X Q Zhou; J M McGinness; W S Griffin
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

Review 9.  Glial cell dysregulation: a new perspective on Alzheimer disease.

Authors:  Rommy von Bernhardi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

Review 10.  Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.

Authors:  W Sue T Griffin; Robert E Mrak
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.